INTL

KORITE PARTNERS WITH KAIMIRRA TUTAN

LUXURY BRAND KAIMIRRA TUTAN TO BE THE EXCLUSIVE DISTRIBUTORFOR KORITE JEWELLERY IN ASIA Two iconic Canadian brands, KORITE and Kaimirra Tutan, held a signing ceremony today celebrating a joint partnership which will appoint Kaimirra Tutan as the exclusive distributor of KORITE jewellery, ammolite and Canadian ammonites for Asian countries/regions such as Malaysia, Singapore, Thailand, and […]

thaipr.net

21 ธ.ค. 65

PeproMene Bio, Inc. Announced Complete Response of The First Patient Treated in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope

PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first patient treated in its phase 1 relapsed or refractory B-cell Non-Hodgkin Lymphoma (r/r B-NHL) clinical trial of PMB-CT01 (BAFFR-CAR T Cells) has reached Complete Response at 1-month post treatment. The trial is taking place […]

thaipr.net

21 ธ.ค. 65

“เอฟเท็น” จัดโปรแกรมเค-สตาร์ทอัพ เซ็นเตอร์ สิงคโปร์ ประจำปี 2565 ปิดฉากลงด้วยความสำเร็จในการปั้นสตาร์ทอัพ

โปรแกรมดังกล่าวมุ่งเจาะกลุ่มสตาร์ทอัพมาแรงของเกาหลีในแวดวงฟินเทคและสมาร์ทซิตี้ เพื่อขยายธุรกิจในสิงคโปร์ เอฟเท็น (F10) ระบบนิเวศนวัตกรรมระดับโลกและนักลงทุนระยะแรกเริ่ม ประกาศความสำเร็จของโครงการเค-สตา…

thaipr.net

21 ธ.ค. 65

SI GROUP LAUNCHES DIGITAL PORTAL FOR GLOBAL PERFORMANCE ADDITIVES PORTFOLIO

 Company seeks to enhance customer journey and increase access to product information SI Group, a leading global performance additives company, has launched a product portal to improve and enhance its customers’ product selection experience. The new online solution will transform the customer journey, simplifying product identification and enabling faster access to key product information. The […]

thaipr.net

21 ธ.ค. 65

Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination

Carrick to execute Phase 2 clinical trial in patients with CDK4/6i resistant HR+, HER2- metastatic breast cancer Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, and the Menarini Group (“Menarini”), a privately-held, leading international pharmaceutical company, today announced a clinical trial collaboration and supply agreement. This agreement covers the…

thaipr.net

21 ธ.ค. 65
1 … 888 889 890 891 892 … 2,358

Copyright © 2026 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.